Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
2015 · Journal of Clinical Investigation · 1,411 citations
https://doi.org/10.1172/jci80011
X
Xue Han
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
4.1K
Citations
24
h-index
39
i10-index
Xue Han is an academic researcher from Shanxi Medical University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers & Hepatitis B Virus Studies. The author has an h-index of 24, co-authored 99 publications.
ORCID: 0000-0001-5016-2356Papers by this author
worksAssociations of socioeconomic factors with cause-specific Mortality and burden of cardiovascular diseases: findings from the vital registration in urban Shanghai, China, during 1974–2015
2020 · BMC Public Health · 50 citations
https://doi.org/10.1186/s12889-020-09390-1
YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment
2021 · Scientific Reports · 30 citations
https://doi.org/10.1038/s41598-021-91623-3
Exosomal lncRNA Mir100hg from lung cancer stem cells activates H3K14 lactylation to enhance metastatic activity in non-stem lung cancer cells
2025 · Journal of Nanobiotechnology · 19 citations
https://doi.org/10.1186/s12951-025-03198-0
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
2023 · Rheumatology and Therapy · 1 citations
https://doi.org/10.1007/s40744-022-00523-z
Development and preliminary verification of the scale of care needs of family caregivers of patients with bladder cancer undergoing urostomy
2025 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-025-12678-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat